The American Red Cross partnered with several organizations to host a metro-wide blood drive to donate to people with sickle ...

Today's health news includes one woman's experience with sickle cell disease, what RFK and Trump can actually do on vaccines, ...

Scientists use gene-altering technologies for many purposes. These technologies can change a person’s DNA to alter physical traits. For example, they might use technology to change a person’s ...

Stay updated on Beam Therapeutics Inc.'s latest advancements in Sickle Cell Disease and alpha-1 antitrypsin deficiency treatments. Click for my BEAM stock update.

The Pt Deendayal Upadhyay Memorial Health Sciences and Ayush University collaborates with CSIR-CCMB to enhance sickle cell anemia diagnosis and genetic research, improving public health outcomes in ...

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, ...

Ghana on Tuesday unveiled a National Sickle Cell Disease (SCD) Strategy aimed at improving both preventive and treatment services for the condition.

Ghana on Tuesday unveiled a National Sickle Cell Disease (SCD) Strategy aimed at improving both preventive and treatment services for the condition.

TDT and SCD are caused by two mutations affecting a key component of hemoglobin, the oxygen-carrying molecule ... transfusion-dependent beta-thalassemia and sickle-cell anemia. Casgevy received ...

On Tuesday, Beam Therapeutics Inc. (NASDAQ:BEAM) announced that 35 patients have cleared screening and enrolled in the BEACON ...

Results from Phase 3 ENERGIZE-T Study of Mitapivat in Transfusion-dependent Thalassemia will be Presented in Oral Session –– Tebapivat Phase 1 ...

Nobel Prize winner and UC Berkeley professor Jennifer Doudna presented developments on her gene research at a UC Santa Barbara Arts & Lectures event on Oct. 22.